Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMPC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,134
Award facts
- Contract value 100% obligated
- $46,134.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $46,134.18 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 9, 2025, with an ultimate completion date of December 17, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents part of a broader $30.3 billion acquisition strategy establishing multiple regional prime vendor contractors to supply branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and specialty pharmaceutical products to military healthcare facilities worldwide. DMS Pharmaceutical Group's extensive product portfolio includes oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals, positioning the company as a key component of the Department of Defense's global medical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEMPC?
SPE2DU26FEMPC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DU26FEMPC worth?
The government has obligated $46,134 on SPE2DU26FEMPC.
Is contract SPE2DU26FEMPC an order under another contract?
Yes. SPE2DU26FEMPC is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMPC competed?
The extent of competition for SPE2DU26FEMPC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award